Specific keynote: chemoprevention of ovarian cancer: the journey begins.

Robert F. Ozols; Mary B. Daly; Andres Klein-Szanto; Thomas C. Hamilton; Robert C. Bast; Molly A. Brewer

doi:10.1006/gyno.2002.6686

Specific keynote: chemoprevention of ovarian cancer: the journey begins.

Robert F. Ozols, Mary B. Daly, Andres Klein-Szanto, Thomas C. Hamilton, Robert C. Bast, Molly A. Brewer

Fox Chase Cancer Center

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Original language	English
Pages (from-to)	S59-66; discussion S67-6670
Journal	Gynecologic Oncology
Volume	88
Issue number	1 Pt 2
DOIs	https://doi.org/10.1006/gyno.2002.6686
State	Published - Jan 2003

Keywords

Anticarcinogenic Agents/therapeutic use
Contraceptives, Oral/therapeutic use
Female
Fenretinide/therapeutic use
Humans
Ovarian Neoplasms/genetics
Ovariectomy
Randomized Controlled Trials as Topic
Risk Factors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1006/gyno.2002.6686

Cite this

@article{e64dbb3ed1bd48a38de8d1233a7fd507,

title = "Specific keynote: chemoprevention of ovarian cancer: the journey begins.",

keywords = "Anticarcinogenic Agents/therapeutic use, Contraceptives, Oral/therapeutic use, Female, Fenretinide/therapeutic use, Humans, Ovarian Neoplasms/genetics, Ovariectomy, Randomized Controlled Trials as Topic, Risk Factors",

author = "Ozols, {Robert F.} and Daly, {Mary B.} and Andres Klein-Szanto and Hamilton, {Thomas C.} and Bast, {Robert C.} and Brewer, {Molly A.}",

year = "2003",

month = jan,

doi = "10.1006/gyno.2002.6686",

language = "English",

volume = "88",

pages = "S59--66; discussion S67--6670",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "1 Pt 2",

}

TY - JOUR

T1 - Specific keynote

T2 - chemoprevention of ovarian cancer: the journey begins.

AU - Ozols, Robert F.

AU - Daly, Mary B.

AU - Klein-Szanto, Andres

AU - Hamilton, Thomas C.

AU - Bast, Robert C.

AU - Brewer, Molly A.

PY - 2003/1

Y1 - 2003/1

KW - Anticarcinogenic Agents/therapeutic use

KW - Contraceptives, Oral/therapeutic use

KW - Female

KW - Fenretinide/therapeutic use

KW - Humans

KW - Ovarian Neoplasms/genetics

KW - Ovariectomy

KW - Randomized Controlled Trials as Topic

KW - Risk Factors

UR - http://www.scopus.com/inward/record.url?scp=0037268313&partnerID=8YFLogxK

U2 - 10.1006/gyno.2002.6686

DO - 10.1006/gyno.2002.6686

M3 - Review article

C2 - 12586088

AN - SCOPUS:0037268313

SN - 0090-8258

VL - 88

SP - S59-66; discussion S67-6670

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - 1 Pt 2

ER -

Specific keynote: chemoprevention of ovarian cancer: the journey begins.

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this